D. Medical Receives CE Mark Approval for "Spring Zone" Durable Insulin Pump

Eddie Staley , Benzinga Staff Writer

January 11, 2012 7:31am Comments

D. Medical Industries Ltd. (Nasdaq: DMED) today announced that the Company, through its wholly owned subsidiary Spring Health Solution Ltd., received a CE Mark approval for its Spring™ Zone Insulin Delivery System. "Spring Zone" replaces D. Medical's first generation Spring ADI insulin pump.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: News FDA

1	TSLA, CCIV: Lucid Motors Confirms SPAC Merger With Churchill Capital Corp IV
2	GME, AMC: Why AMC Shares Spiked 20% Today
3	GME, MTC: 36 Stocks Moving in Monday's Pre-Market Session
4	$ETH, $BTC: Bitcoin Might Be Tanking But These Ethereum...
5	TSLA: Video: Woman Runs After Driverless Tesla...
6	$ETH, TSLA: Elon Musk Lost $15B In A Singl...
7	KOS, SXTC: 48 Stocks Moving in T...

1	DISH, EXPI: Cramer Weighs In On Canopy Growth, Dish Network And More
2	PFE: Pfizer's Tick-Borne Encephalitis Vaccine Gets Priority Review...
3	NVAX, TAK: Takeda Doses First Participant In Novavax COVID-19 Vaccine...
4	HYMPY, HYMPF: Hyundai To Replace 82,000 EV Battery Systems I...
5	Premium: NBA Legend Chris Webber's $100M...
6	NVDA, SQ: A Peek Into The Markets: US Stock Futu...
7	TSM: TSM Raises $326.8M From VisEra Shar...

+

+

Market Overview

Tickers

Articles

Keywords

D. Medical Receives CE Mark Approval for "Spring Zone" Durable Insulin Pump

Related Articles (DMED)